If the Trump White House is serious about its push to make medicines more affordable, it should ensure CMS officials never make this mistake again.
New open-source AI skill converts HTML design templates quickly into a fully-managed website within minutes. Instead of ...
On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...
In the wake of the Food and Drug Administration’s (FDA’s) controversial decision to approve aducanumab for Alzheimer’s disease, how will, and how should, Medicare respond? We propose a coverage with ...
Last month, the Centers for Medicare and Medicaid (CMS) released a draft memorandum regarding its national coverage determination of the class of monoclonal antibodies directed at beta-amyloid plaque ...
The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...
As the digital landscape continues to grow, businesses must pursue their customers in every possible location, which means scalable, high-performance solutions with omnichannel accessibility needs and ...
CMS’ Innovation Center is offering the third and final session of its ACO Accelerated Development Learning Sessions. ACO Accelerated Development Learning Sessions are designed to provide executive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results